XBIT (XBiotech) Accounts Payable: $0.86 Mil (As of Mar. 2026)


XBIT XBiotech Inc XBIT
30 GF Score
Price $2.30
! 2 Warning Signs
View Full Analysis

What is XBiotech Accounts Payable?

XBiotech XBIT 30 Accounts Payable is $0.86 Mil as of Mar. 2026. GuruFocus rates XBIT with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

XBiotech's Accounts Payable for the quarter that ended in Mar. 2026 was $0.86 Mil.

XBiotech's quarterly Accounts Payable increased from Sep. 2025 ($1.04 Mil) to Dec. 2025 ($1.54 Mil) but then declined from Dec. 2025 ($1.54 Mil) to Mar. 2026 ($0.86 Mil).

XBiotech's annual Accounts Payable declined from Dec. 2023 ($2.52 Mil) to Dec. 2024 ($2.22 Mil) and declined from Dec. 2024 ($2.22 Mil) to Dec. 2025 ($1.54 Mil).

XBiotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for XBiotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XBiotech Accounts Payable Chart

XBiotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.07 2.41 2.52 2.22 1.54

XBiotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 1.43 1.04 1.54 0.86
XBIT
30GF Score
XBiotech Inc XBIT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

XBiotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.86 Mil mean?
XBiotech (XBIT) has a Accounts Payable of $0.86 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on XBiotech and its competitors.
Is XBiotech's Accounts Payable too high?
XBiotech's current Accounts Payable is $0.86 Mil. Overall, XBiotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does XBiotech's Accounts Payable compare to ACRV and EXOZ?
XBiotech's Accounts Payable of $0.86 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on XBiotech and its competitors. XBiotech's current Accounts Payable is $0.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XBiotech stock overvalued right now?
XBiotech (XBIT) has a current Accounts Payable of $0.86 Mil. The current Accounts Payable is $0.86 Mil. XBiotech's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For XBiotech (XBIT), the current Accounts Payable is $0.86 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

XBiotech Business Description

Other Exchanges 4XB:Germany
Address 5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
30GF Score

Get the complete analysis for XBIT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.30
Price